Aug 2026· European Heart Journal, Supplement· 0 citations
TL;DR
In this population-based cohort study, the five-year incidence of cancer following a new diagnosis of CVD was markedly high and the distribution of cancer types in this population differed from that of the general population, with a higher proportion of genitourinary cancers and a lower proportion of breast cancer.
Abstract
Patients with cardiovascular disease (CVD) have an increased risk of cancer, partly due to shared risk factors, chronic inflammation and systemic mediators. However, most previous studies have focused on individuals with pre-existing CVD. Whether patients with a new diagnosis of CVD are at particularly high risk of incident cancer, and whether the spectrum of cancer types differs from that of the general population, remains insufficiently explored.
To describe the five-year incidence of cancer in patients with a new diagnosis of CVD in our healthcare area and to compare the distribution of cancer types with that reported in the general population.
We conducted a population-based cohort study using clinical databases from our healthcare area. All adults (>18 years) without a previous history of cancer who were newly diagnosed with CVD between 2010 and 2022 were included. Incident cancers diagnosed between 3 months and 5 years after the index CVD diagnosis were recorded. The incidence and distribution of cancer types were analysed and compared with data from the general population.
A total of 9,900 patients with newly diagnosed CVD and no prior cancer history were identified. The mean age of the cohort was 64 years, 43% were women, and comorbidities were frequent. During follow-up, 1,922 patients (19.4%) developed incident cancer within five years. Patients who developed cancer were more often male, older, and had a higher burden of comorbidities than those who did not. Among CVD subtypes, chronic heart failure was associated with the highest risk of incident cancer. The most frequently diagnosed cancers were gastrointestinal (27%), lung (14.5%), genitourinary (13.5%) and male reproductive system cancers (13.4%).
In our healthcare area, the five-year incidence of cancer following a new diagnosis of CVD was markedly high. Moreover, the distribution of cancer types in this population differed from that of the general population, with a higher proportion of genitourinary cancers and a lower proportion of breast cancer. These findings highlight the importance of cancer awareness and surveillance strategies in patients with newly diagnosed CVD.Table.Basal characteristics. Figure.Types of incident cancer.
Patients with newly diagnosed CVD present a higher risk of cancer when compared to patients without a history of prior CVD, and men show a higher risk of incident cancer over time when patients with CVD are subclassified by biological sex, when patients with CVD are subclassified by biological sex.
H. Morillas Climent, P. Moliner, A. Ricarte-Marin et al.· European Heart Journal, Supp...· 0 citations
BACKGROUND AND AIMS
The incidence of cancer in people with cardiovascular disease (CVD) is poorly understood. This study aimed to understand the sex differences in incident cancer and cancer-related mortality in people with and without CVD.
METHODS
Participants were drawn from the European Prospective Investigation i...
R. Thuemmler, T. Pana, M. Mamas et al.· European Heart Journal· 0 citations
Evaluating the occurrence of new-onset CVD in women with breast cancer undergoing chemotherapy and identifying factors associated with increased risk of cardiovascular disease highlights the need for sustained cardiovascular surveillance in breast cancer survivors.
V. Dvorovy, L. Kováčová, M. Selvek et al.· European Heart Journal, Supp...· 0 citations
The burden of pre-existing CVD at cancer diagnosis has increased substantially over the past two decades in the UK and is projected to rise further, highlighting the growing need for integrated prevention strategies and cardio-oncology services to address increasing multimorbidity in patients with cancer.
A. Alshahrani, E. Kontopantelis, C. Morgan et al.· European Heart Journal, Supp...· 0 citations
BACKGROUND AND AIMS
Advances in cancer care have improved survival, increasing the importance of comorbidities at diagnosis for longer-term outcomes. Pre-existing cardiovascular disease (CVD) can complicate management and prognosis, yet its long-term trends and future burden at cancer diagnosis are unclear. This study...
A. Alshahrani, E. Kontopantelis, C. Morgan et al.· European Heart Journal· 0 citations
Abstract Background Cancer and stroke are major causes of morbidity and mortality, with an increasing shared burden. This study aimed to provide population‐based estimates of ischemic stroke (IS) risk after cancer diagnosis across multiple cancer sites and demographic subgroups. Methods A retrospective cohort study was...
C. Libruder, D. Tanne, B. Silverman et al.· Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.